CPIM
TMO icon

Coalescence Partners Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Coalescence Partners Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,072
Closed -$14.6M – 18
2024
Q4 		$14.6M Buy
28,072
+11,895
+74% +$6.54M 5.53% 10
2024
Q3 		$10M Sell
16,177
-7,566
-32% -$4.48M 4.48% 12
2024
Q2 		$13.1M Buy
23,743
+37
+0.2% +$21.2K 10.77% 5
2024
Q1 		$13.8M Buy
23,706
+8,489
+56% +$4.76M 10.89% 4
2023
Q4 		$8.08M Buy
+15,217
New +$7.37M 7.21% 6

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Coalescence Partners Investment Management's TMO Position: Q1 2025 in Review

Coalescence Partners Investment Management sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 28,072 shares — an estimated $14.6M sold.

Coalescence Partners Investment Management first reported a position in TMO in Q4 2023 and held it in 5 quarters. The position peaked at $14.6M in Q4 2024. 2,578 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Coalescence Partners Investment Management reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Coalescence Partners Investment Management sold 28,072 Thermo Fisher Scientific shares in Q1 2025, an estimated $14.6M.
  • Coalescence Partners Investment Management first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 5 quarters.
  • Coalescence Partners Investment Management's Thermo Fisher Scientific position peaked at $14.6M in Q4 2024.
  • 2,578 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Coalescence Partners Investment Management's 13F filing for Q1 2025, filed 14 May 2025.